Literature DB >> 29159514

Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in the perioperative setting.

Sharon C Peacock1, Julie A Lovshin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29159514     DOI： 10.1007/s12630-017-1019-5

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  5 in total

1.  [Severe SGLT-2 inhibitor-induced euglycemic ketoacidosis-a rare but serious complication].

Authors:  E Rotsel; U Pietsch
Journal:  Anaesthesist       Date:  2019-12-05       Impact factor: 1.041

Review 2.  [Treatment of diabetes mellitus in perioperative medicine-an update].

Authors:  B Rupprecht; A Stöckl; S Stöckl; C Dietrich
Journal:  Anaesthesist       Date:  2020-11-03       Impact factor: 1.041

3.  Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2018-05-01       Impact factor: 29.690

4.  A survey: perioperative diabetes medications and glucose control-time to re-examine management?

Authors:  Russell Brown; Urooj Siddiqui; James Paul
Journal:  Can J Anaesth       Date:  2019-02-06       Impact factor: 5.063

Review 5.  Insight Into the Perioperative Management of Type 2 Diabetes.

Authors:  Syed Owais Zaidi; Yusra Khan; Bibi S Razak; Bilal Haider Malik
Journal:  Cureus       Date:  2020-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.